Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.
Montai Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
Montai Therapeutics's investors include Flagship Pioneering.
Montai Therapeutics is headquartered in Cambridge, United States.
Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.
Montai Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Montai Therapeutics — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/montai-therapeutics. Accessed August 17, 2026.
VCBacked. (2022). Montai Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/montai-therapeutics
{{cite web |title=Montai Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/montai-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated